Pilot Test for a Newly Developed Nutrition Screening Method: Pediatric Subjective Global Assessment

This study has been completed.
Sponsor:
Information provided by:
St. Jude Children's Research Hospital
ClinicalTrials.gov Identifier:
NCT00665691
First received: April 22, 2008
Last updated: June 1, 2011
Last verified: June 2011
  Purpose

Researchers are studying ways to predict if cancer patients are at risk for poor nutrition during their chemotherapy treatment. They hope to identify children with nutrition problems early in treatment. This may help prevent weight loss and other nutrition problems later in treatment.


Condition Intervention
Compare Two Nutrition Screening Tools
Other: Nutritional Screening Tools

Study Type: Observational
Official Title: Pilot Test for a Newly Developed Nutrition Screening Method: Pediatric Subjective Global Assessment

Resource links provided by NLM:


Further study details as provided by St. Jude Children's Research Hospital:

Primary Outcome Measures:
  • To compare the ability of two nutrition screening tools to identify nutritionally at risk patients [ Time Frame: Within 90 days of study completion ] [ Designated as safety issue: No ]

Estimated Enrollment: 132
Study Start Date: September 2003
Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
1 Other: Nutritional Screening Tools
To compare the nutrition risk identification abilities of two nutrition screening tools: PEDSGA tool and the standard assessment tool.

Detailed Description:

The PEDSGA is a newly developed nutrition tool that includes a training manual that be used to teach health care professionals to identify at-risk patients by doing a nutrition physical exam. The PEDSGA also includes questions that the patient/caregiver answers regarding appetite, recent treatment, and activity level. This method of screening is new and may be able to identify at-risk patients better than the standard method. This study will use both methods and evaluate the two, in hope of determining which method works best to identify at-risk patients.

  Eligibility

Ages Eligible for Study:   2 Years to 16 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Participant is between 2 and 16 years of age and receiving treatment for a hematologic or solid malignancy at St. Jude Children's Research Hospital.

Criteria

Inclusion Criteria:

  • St. Jude Children's Research Hospital patient between 2 and 16 years of age who is actively receiving treatment for a hematologic or solid tumor malignancy
  • Patient is not admitted to the transplant service
  • Patient is able to read English or Spanish
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00665691

Locations
United States, Tennessee
St. Jude Children's Research Hospital
Memphis, Tennessee, United States, 38105
Sponsors and Collaborators
St. Jude Children's Research Hospital
Investigators
Principal Investigator: Karen Smith, RD, MS, LDN St. Jude Children's Research Hospital
  More Information

Additional Information:
No publications provided

Responsible Party: Karen Smith, RD, MS, LDN, St. Jude Children's Research Hospital
ClinicalTrials.gov Identifier: NCT00665691     History of Changes
Other Study ID Numbers: PEDSGA
Study First Received: April 22, 2008
Last Updated: June 1, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by St. Jude Children's Research Hospital:
All Malignancies

ClinicalTrials.gov processed this record on July 22, 2014